127 related articles for article (PubMed ID: 11830556)
21. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs.
Song I; Brown DR; Wiltshire RN; Gantz I; Trent JM; Yamada T
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9085-9. PubMed ID: 8415658
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.
Merendino L; Guth S; Bilbao D; Martínez C; Valcárcel J
Nature; 1999 Dec; 402(6763):838-41. PubMed ID: 10617208
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin receptors in human pancreatic cancer cell lines.
Mandair KK; Towner P; Stamford IF; Morris JD; Harper E; Benjamin IS; Tavares IA
Eur J Cancer; 1998 Aug; 34(9):1455-9. PubMed ID: 9849431
[TBL] [Abstract][Full Text] [Related]
24. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
25. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning, developmental expression and pharmacological characterization of the CCKB/gastrin receptor in the calf pancreas.
Dufresne M; Escrieut C; Clerc P; Le Huerou-Luron I; Prats H; Bertrand V; Le Meuth V; Guilloteau P; Vaysse N; Fourmy D
Eur J Pharmacol; 1996 Feb; 297(1-2):165-79. PubMed ID: 8851180
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
Chand HS; Ness SA; Kisiel W
Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
[TBL] [Abstract][Full Text] [Related]
28. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181
[TBL] [Abstract][Full Text] [Related]
29. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth.
Hellmich MR; Rui XL; Hellmich HL; Fleming RY; Evers BM; Townsend CM
J Biol Chem; 2000 Oct; 275(41):32122-8. PubMed ID: 10913157
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer.
Moonka R; Zhou W; Bell RH
J Gastrointest Surg; 1999; 3(2):134-40. PubMed ID: 10457335
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of 5'-end alternatively spliced human cholecystokinin-B receptor mRNAs.
Monstein HJ; Nilsson I; Ellnebo-Svedlund K; Svensson SP
Recept Channels; 1998; 6(3):165-77. PubMed ID: 10100325
[TBL] [Abstract][Full Text] [Related]
32. Molecular structure of the mouse CCK-A receptor gene.
Lacourse KA; Lay JM; Swanberg LJ; Jenkins C; Samuelson LC
Biochem Biophys Res Commun; 1997 Jul; 236(3):630-5. PubMed ID: 9245702
[TBL] [Abstract][Full Text] [Related]
33. Expression of a 70-kDa immunoreactive form of bile salt-dependent lipase by human pancreatic tumoral mia PaCa-2 cells.
Pasqualini E; Caillol N; Panicot L; Valette A; Lombardo D
Arch Biochem Biophys; 2000 Mar; 375(1):90-100. PubMed ID: 10683253
[TBL] [Abstract][Full Text] [Related]
34. Alternative modes of binding by U2AF65 at the polypyrimidine tract.
Henscheid KL; Voelker RB; Berglund JA
Biochemistry; 2008 Jan; 47(1):449-59. PubMed ID: 18067274
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
36. Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.
Soares LM; Zanier K; Mackereth C; Sattler M; Valcárcel J
Science; 2006 Jun; 312(5782):1961-5. PubMed ID: 16809543
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
38. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
[TBL] [Abstract][Full Text] [Related]
39. RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts.
Pacheco TR; Moita LF; Gomes AQ; Hacohen N; Carmo-Fonseca M
Mol Biol Cell; 2006 Oct; 17(10):4187-99. PubMed ID: 16855028
[TBL] [Abstract][Full Text] [Related]
40. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
Günther R; Carstens OC; Schmidt WE; Fölsch UR
Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
